Camila Barcellos Calderipe

Camila Barcellos Calderipe

Auto-generated profile, based on publicly available information

Camila Barcellos Calderipe

Department of Oral Diagnosis Dental School University of Campinas (UNICAMP), Piracicaba Piracicaba São Paulo Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2021 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
LFL. dos Santos Ferreira
L. dos Santos Ferreira
LALucas Guimarães Abreu
Lucas Guimarães Abreu
CCC. B. Calderipe
C. B. Calderipe
MMManoela Domingues Martins
Manoela Domingues Martins
LSL. F. Schuch
L. F. Schuch
AVA. C. U. Vasconcelos
A. C. U. Vasconcelos

1 January 2024 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
ASAlini Cardoso Soares
Alini Cardoso Soares
AGAna Paula Neutzling Gomes
Ana Paula Neutzling Gomes
CCCamila Barcellos Calderipe
Camila Barcellos Calderipe
Fernanda Gonçalves SalumFernanda Gonçalves Salum
Fernanda Gonçalves Salum
KCKaren Cherubini
Karen Cherubini
AVAna Carolina Uchoa Vasconcelos
Ana Carolina Uchoa Vasconcelos
The objective of the present study was to investigate the frequency of oral leukoplakia and oral erythroplakia among young patients from three Brazilian reference centers in Oral and Maxillofacial Pathology. A retrospective study was carried out from 2011 to 2021 on 861 patients diagnosed with oral leukoplakia and oral erythroplakia. Demographic and clinicopathological data were evaluated. Fisher’s exact test was used to evaluate the association among sex, age, anatomical location, and histopathological diagnosis. A total of 83 (9.64%) cases involved young patients (aged 0.05). Oral leukoplakia and oral erythroplakia are uncommon diseases in young patients. In this population, oral leukoplakia shows a slight predilection for women aged between 30 and 39 years.

20 February 2024 in Special Care in Dentistry
Verified
Journal Article
Closed access
LKLaura Borges Kirschnick
Laura Borges Kirschnick
CCCamila Barcellos Calderipe
Camila Barcellos Calderipe
AVAlessandro Villa
Alessandro Villa
ESErison Santana dos Santos
Erison Santana dos Santos
CMCesar Migliorati
Cesar Migliorati
Alan Roger Santos-SilvaAlan Roger Santos-Silva
Alan Roger Santos-Silva

2 July 2025 in Oral Diseases
Verified
Journal Article
Open access
CCCamila Barcellos Calderipe
Camila Barcellos Calderipe
LKLaura Borges Kirschnick
Laura Borges Kirschnick
ASAlini Cardoso Soares
Alini Cardoso Soares
AVAna Carolina Uchoa Vasconcelos
Ana Carolina Uchoa Vasconcelos
MLMárcio Ajudarte Lopes
Márcio Ajudarte Lopes
Alan Roger Santos-SilvaAlan Roger Santos-Silva
Alan Roger Santos-Silva
Objective: This review aimed to: (i) identify the variables used by oral medicine services (OMS) to describe the scope of their clinical practices and (ii) identify gaps in the availability of these variables in the literature to guide future research on the characterisation of OM practices. To address the following question: What characteristics from studies on clinical practice have been used to describe the scope of practice in OM? Material and Methods: This scoping review followed the PRISMA‐ScR guidelines. Electronic searches were conducted in the following databases: PubMed, Scopus, Embase, Web of Science, LILACS and grey literature. The presence of the following variables was assessed: referral source, age, sex, medical profile, diagnosis, procedures and follow‐up. Results: A total of 12 studies met the eligibility criteria, comprising 15 OMS across 10 countries and including 114,971 patients. Some studies specifically aimed to characterise OMS practice, while others focused on specific aspects of these practices. Most studies examined variables such as referral source, age, sex and diagnosis. Conclusions: There are gaps in the description of the OMS scope of practice in the literature, particularly regarding patient follow‐up, characterisation of the range of procedures performed and documentation of patients' medical profiles.

21 February 2026 in Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
PDF file
ASAlini Cardoso Soares
Alini Cardoso Soares
GBGabriel Lima Braz
Gabriel Lima Braz
AFAmanda dos Santos Figueiredo
Amanda dos Santos Figueiredo
CCCamila Barcellos Calderipe
Camila Barcellos Calderipe
FCFrancisco Samuel Rodrigues Carvalho
Francisco Samuel Rodrigues Carvalho
AVAna Carolina Uchoa Vasconcelos
Ana Carolina Uchoa Vasconcelos
Purpose: This systematic review aimed to synthesize the available clinicopathological data on nasopalatine duct cyst (NPDC). Methods: Electronic searches were performed in seven databases and the grey literature, according to the PRISMA 2020 statement. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool. Data were analysed using descriptive statistics. Results: A total of 168 studies comprising 2,734 NPDC cases were included. Most lesions were asymptomatic ( n = 358/54.16%) and occurred in males ( n = 1641/60.75%), with individuals in the fourth and fifth decade of life being the most frequently affected. Periapical radiographs ( n = 181/40.31%) and computed tomography scan ( n = 159/35.41%) were the most commonly used imaging modalities. Metaplasia ( n = 278/58.28%) was observed in most cases with a predominance of combinations involving stratified squamous epithelium and pseudostratified ciliated columnar epithelium ( n = 78/47.27%). The periapical cyst was the second most frequent clinical diagnostic hypothesis. Enucleation was the preferred treatment modality ( n = 544/95.94%), and recurrence was absent in most cases ( n = 375/93.05%). Conclusion: NPDC is a benign lesion with a heterogeneous clinical presentation and a low recurrence rate. Its anatomical location frequently results in diagnostic overlap with odontogenic lesions, particularly periapical chronic lesions. Clinicians should be aware of its clinicopathological features and integrate clinical, radiographic, and histopathological findings to ensure accurate diagnosis and appropriate management.

14 May 2026 in Lasers in Dental Science
Verified
Journal Article
Open access
PDF file
CCCamila Barcellos Calderipe
Camila Barcellos Calderipe
ASAlini Cardoso Soares
Alini Cardoso Soares
MRMarco Túlio Leandro Ribeiro
Marco Túlio Leandro Ribeiro
MLMárcio Ajudarte Lopes
Márcio Ajudarte Lopes
ASAlan Roger Santos-Silva
Alan Roger Santos-Silva
AVAna Carolina Uchoa Vasconcelos
Ana Carolina Uchoa Vasconcelos
Purpose: To assess the features of the 100 most-cited articles on adjunctive therapy strategies for Medication-Related Osteonecrosis of the Jaw (MRONJ). Methods: The 100 most-cited articles related to adjunctive therapies for MRONJ were collected from the Web of Science. The following information was extracted from the papers: authorship, title of the paper, number of citations, the publication’s year and country, study design, journal title and impact factor, and adjunctive therapy strategies. Temporal distribution of the identified therapies was also analyzed. Results: The 100 articles received a total of 6,095 citations over an 18-year period, with a notable concentration of publications from Italy. Most were descriptive observational studies, published in 55 different journals with impact factors ranging from 0.3 to 41.9. A total of 24 distinct adjunctive therapies were identified. Light-based therapies were the most prominent category ( n = 35/28.9%), encompassing photobiomodulation, laser ablation, and antimicrobial photodynamic therapy. Notably, photobiomodulation showed consistent representation throughout the entire study period, reflecting sustained interest in this modality. Conclusion: The wide range of adjunctive therapies underscores the complexity of MRONJ management. Light-based therapies were the most prominent category identified, highlighting the relevance of laser-based approaches in MRONJ management. However, higher-quality evidence is required, particularly well-designed randomized clinical trials, to clarify the clinical applicability of adjunctive therapies in MRONJ.